C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:
“Thank you the Hematology Society of Taiwan for inviting me to speak about ‘novel insights on BCMA-targeted monoclonal antibodies in myeloma’ at your conference – great meeting with lots of new data!”
Source: C. Ola Landgren/X